TWA
FOMX

TCI Wealth Advisors’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

TCI Wealth Advisors’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-800
Closed -$3K – 1879
2019
Q4 		$3K Buy
+800
New +$2.54K ﹤0.01% 1082

TCI Wealth Advisors's FOMX Position: Q1 2020 in Review

TCI Wealth Advisors sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 800 shares — an estimated $3K sold.

TCI Wealth Advisors first reported a position in FOMX in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • TCI Wealth Advisors reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • TCI Wealth Advisors sold 800 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $3K.
  • TCI Wealth Advisors first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2019 and held it in 1 quarter.
  • TCI Wealth Advisors's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $3K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on TCI Wealth Advisors's 13F filing for Q1 2020, filed 14 Apr 2020.